Continue Reading
Full article on Yahoo Finance
Longeveron Announces 1-for-10 Reverse Stock Split
Market Intelligence Analysis
AI-Powered 50% FREE-ANALYSIS-RULE-BASED-ANALYSIS
Why This Matters
Analysis of stock market developments showing neutral sentiment.
Sentiment
Neutral
AI Confidence
50%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Stephen Willard Stephen Willard, Chief Executive Officer, Longeveron Inc. (LGVN) MIAMI, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that the Company will undertake a 1-for-10 reverse split of the Company’s Class A common stock, par value $0.001 per share and Class B common stock, par value $0.001 per share (collectivel
AI Breakdown
Summary
Analysis of stock market developments showing neutral sentiment.
Time Horizon
Short Term
Original article published by
Yahoo Finance
on August 24, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.